Young Matthew P.

Young Matthew P. is listed in filings as Director at CytomX Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 13, 2025, including 1 public disclosure. Recent filings connect the profile to CytomX Therapeutics, Inc. (CTMX). The current snapshot covers public activity from Jun 13, 2025. Reported amounts are shown as $107.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.